Tumor organoids can serve as a viable alternative to drugs for cancer patients, allowing for the evaluation of chemotherapy drugs, targeted drugs, immunotherapy, and various combination treatment options. They possess the ability to accurately predict the effectiveness of anticancer drugs, and exhibit high-throughput and high-specificity characteristics, making them an ideal tool for precise treatment of cancer patients.

scope of application;

●    Thoracic tumors, digestive tract tumors, urinary system tumors, reproductive system tumors and other cancer diseases.

●    Applicable to patients with postoperative adjuvant chemotherapy, first-line drug evaluation, and second- and third-line treatment options.